Low level of HBV-DNA is the most powerful predictive factor of better response to IFN-α therapy in chronic hepatitis B

✍ Scribed by K. Simon; A. Gładysz; M. Zalewska; K. Rotter; W. Dobracki; A. Głowacki; M. Inglot; B. Knysz; A. Machaj; P. Piszko

• Book ID: 118568787
• Publisher: Elsevier Science
• Year: 1998
• Tongue: English
• Weight: 153 KB
• Volume: 28
• Category: Article
• ISSN: 0168-8278
• DOI: 10.1016/s0168-8278(98)81020-9